TickerGuard
Buy Day today: Neutral (46) Mixed market breadth · no major macro event
TVRD

Tvardi Therapeutics, Inc.

Healthcare · Biotechnology

0.7928$ -8.1% vs. previous close Closing price · As of: Oct 30, 2026

Statements

Income Statement

Tvardi Therapeutics, Inc. (TVRD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 0.0 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TVRD
Line item 2020 2021 2022 2023 2024 2025
135 23 42 21 7.1 0.0
– 1.6 7.5 6.4 0.8 0.1
– 21 34 15 6.3 -0.1
108 83 92 108 33 18
– – 2.7 2.8 4.5 8.7
129 111 122 136 62 27
5.4 -89 -88 -121 -56 -27
– – 0.0 0.0 8.5 –
7.7 -88 -85 -119 -71 -18
-0.7 – – – -0.4 –
8.4 -88 -85 -119 -71 -18
8.7 -87 -85 -118 -63 -18

Data as of: October 30, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?